Financhill
Sell
34

FBIO Quote, Financials, Valuation and Earnings

Last price:
$1.62
Seasonality move :
-6.14%
Day range:
$1.60 - $1.71
52-week range:
$1.36 - $2.89
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.31x
P/B ratio:
2.10x
Volume:
234.6K
Avg. volume:
339.8K
1-year change:
-19.5%
Market cap:
$44.4M
Revenue:
$84.5M
EPS (TTM):
-$13.27

Earnings Data

Next earnings date for FBIO
May 15
2025
Most recent earnings per share
-$0.76
Missed by $0.49
(Nov 14/2024)
Consensus Estimate
-$0.27
(Nov 14/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

FBIO Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/15/2025 Q1 $11.8M -- -- -- --
03/26/2025 Q4 $16.3M -- -- -$0.75 --
11/14/2024 Q3 $32.2M $14.6M -$0.76 -$0.27 -$0.49
08/14/2024 Q2 $14.8M $14.9M -$10.95 -- --
05/14/2024 Q1 $14.1M $13M -$1.03 -- --
03/18/2024 Q4 $15.1M $19.9M -$0.53 -$1.49 $0.96
11/07/2023 Q3 $15.9M $34.8M -$0.94 -$1.50 $0.56
08/14/2023 Q2 $17.5M $17.4M -$3.65 -$0.90 -$2.75
05/15/2023 Q1 $20.3M $12.4M -$3.47 $0.45 -$3.92
03/30/2023 Q4 $22.1M $16.4M -$4.81 -$0.08 -$4.74
09/30/2022 Q3 $21.6M $16.5M -$4.11 -$1.05 -$3.06
08/11/2022 Q2 -- $18.9M -$3.90 -- --
05/10/2022 Q1 -- $23.9M -$2.70 -- --
03/28/2022 Q4 -- $18.3M -$5.70 -- --
11/04/2021 Q3 -- $21.1M -$3.90 -- --
08/16/2021 Q2 -- $17.8M -$0.60 -- --
05/06/2021 Q1 -- $11.6M -$1.65 -- --
03/31/2021 Q4 -- $13.7M -$0.90 -- --
11/09/2020 Q3 -- $9.5M -$3.00 -- --
08/05/2020 Q2 -- $9.5M -$2.85 -- --
05/06/2020 Q1 -- $12.9M -$2.85 -- --
03/11/2020 Q4 -- $11.1M -$4.05 -- --
11/04/2019 Q3 -- $9.8M -$3.30 -- --
08/09/2019 Q2 -- $9.3M -$3.60 -- --
03/31/2019 Q1 -- $6.5M $0.30 -- --
12/31/2018 Q4 -- $9M -$8.70 -- --
09/30/2018 Q3 -- $5.2M -$5.55 -- --
06/30/2018 Q2 -- $6.8M -$7.50 -- --
03/31/2018 Q1 -- $5.9M -$7.35 -- --
12/31/2017 Q4 -- -$125M -$3.30 -- --
09/30/2017 Q3 -- $46.9M -$10.05 -- --
06/30/2017 Q2 -- $50.7M -$6.45 -- --
03/31/2017 Q1 -- $44.7M -$4.50 -- --
12/31/2016 Q4 -- $12.6M -$6.60 -- --
09/30/2016 Q3 -- $975K -$4.80 -- --
06/30/2016 Q2 -- $2.2M -$4.65 -- --
03/31/2016 Q1 -- $660K -$4.65 -- --
12/31/2015 Q4 -- $338K -$4.65 -- --
09/30/2015 Q3 -- $25K -$6.90 -- --
06/30/2015 Q2 -- -- -$2.40 -- --
03/31/2015 Q1 -- $500K -$4.65 -- --

Fortress Biotech Earnings Questions

  • How Much did Fortress Biotech Generate in Revenue Last Quarter?

    Fortress Biotech reported $14.6M worth of top line sales in its most recent quarter.

  • Did Fortress Biotech Beat Earnings Last Quarter?

    Fortress Biotech announced earnings per share of -$0.76 which represents a miss of analyst forecast a -$0.27 per share.

  • Is Fortress Biotech Profitable?

    Fortress Biotech reported $9.3M that represents $0.47 per share over the last quarter.

  • What is the Analyst Consensus for Fortress Biotech EPS Next Year?

    Fortress Biotech's earnings are forecast to decrease from -$8.47 per share to -$0.87 per share next year representing a decrease of -89.73%.

  • When is Fortress Biotech's Earnings Date?

    Fortress Biotech's next earnings date is May 15, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is JHX Stock a Buy Sell or Hold?
Is JHX Stock a Buy Sell or Hold?

James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…

Why Did Buffett Sell the S&P 500?
Why Did Buffett Sell the S&P 500?

Warren Buffett has always been an advocate of investing in…

Will SoundHound AI Stock Recover?
Will SoundHound AI Stock Recover?

SoundHound AI (NASDAQ:SOUN) is a leading maker of artificial intelligence…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 37x

Alerts

Buy
78
AJINY alert for Mar 29

Ajinomoto [AJINY] is up 99.61% over the past day.

Buy
69
AGX alert for Mar 29

Argan [AGX] is up 19.83% over the past day.

Sell
24
AIR alert for Mar 29

AAR [AIR] is down 16.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock